Journal for ImmunoTherapy of Cancer (Nov 2023)
493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoral in vivo efficacies in humanized preclinical models
- Vanessa Gauttier,
- Marion Drouin,
- Caroline Mary,
- Géraldine Teppaz,
- Ariane Desselle,
- Virginie Thépénier,
- Emmanuelle Wilhelm,
- Elise Chiffoleau,
- Nicolas Poirier,
- Isabelle Girault,
- Cecile Batty,
- Marine Malloci,
- Julien Taurelle,
- Irène Baccelli,
- Stéphanie Neyton,
- Mylène Deramé,
- Kevin Biteau,
- Marion Colonello
Affiliations
- Vanessa Gauttier
- OSE Immunotherapeutics, Nantes, France
- Marion Drouin
- 1OSE Immunotherapeutics, Nantes, France
- Caroline Mary
- 1OSE Immunotherapeutics, Nantes, France
- Géraldine Teppaz
- OSE Immunotherapeutics, Nantes, France
- Ariane Desselle
- 1OSE Immunotherapeutics, Nantes, France
- Virginie Thépénier
- 1OSE Immunotherapeutics, Nantes, France
- Emmanuelle Wilhelm
- 1OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Elise Chiffoleau
- 2CRTI – UMR1064, Nantes, France
- Nicolas Poirier
- 1OSE Immunotherapeutics, Nantes, France
- Isabelle Girault
- OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Cecile Batty
- OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Marine Malloci
- OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Julien Taurelle
- OSE Immunotherapeutics, Nantes, France
- Irène Baccelli
- 1OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Stéphanie Neyton
- 1OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Mylène Deramé
- 1OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Kevin Biteau
- 1OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- Marion Colonello
- 1OSE Immunotherapeutics, Nantes, Loire-Atlantique, France
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0493
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
